216 related articles for article (PubMed ID: 21439269)
1. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.
Lv L; Sun Y; Han X; Xu CC; Tang YP; Dong Q
Brain Res; 2011 Jun; 1396():60-8. PubMed ID: 21439269
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.
Lee JY; Kim HS; Choi HY; Oh TH; Ju BG; Yune TY
J Neurochem; 2012 Jun; 121(5):818-29. PubMed ID: 22409448
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
Ren M; Leng Y; Jeong M; Leeds PR; Chuang DM
J Neurochem; 2004 Jun; 89(6):1358-67. PubMed ID: 15189338
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
Butt MU; Sailhamer EA; Li Y; Liu B; Shuja F; Velmahos GC; DeMoya M; King DR; Alam HB
J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia.
Lu WH; Wang CY; Chen PS; Wang JW; Chuang DM; Yang CS; Tzeng SF
J Neurosci Res; 2013 May; 91(5):694-705. PubMed ID: 23404572
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science.
Abdanipour A; Schluesener HJ; Tiraihi T
Iran Biomed J; 2012; 16(2):90-100. PubMed ID: 22801282
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Valproic Acid in a Rat Model of Cauda Equina Injury.
Kong QJ; Wang Y; Liu Y; Sun JC; Xu XM; Sun XF; Shi JG
World Neurosurg; 2017 Dec; 108():128-136. PubMed ID: 28867325
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro.
Lv L; Han X; Sun Y; Wang X; Dong Q
Exp Neurol; 2012 Feb; 233(2):783-90. PubMed ID: 22178331
[TBL] [Abstract][Full Text] [Related]
13. Cell protective mechanism of valproic acid in lethal hemorrhagic shock.
Li Y; Liu B; Sailhamer EA; Yuan Z; Shults C; Velmahos GC; deMoya M; Shuja F; Butt MU; Alam HB
Surgery; 2008 Aug; 144(2):217-24. PubMed ID: 18656628
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3.
Chen S; Ye J; Chen X; Shi J; Wu W; Lin W; Lin W; Li Y; Fu H; Li S
J Neuroinflammation; 2018 May; 15(1):150. PubMed ID: 29776446
[TBL] [Abstract][Full Text] [Related]
15. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
16. Characterization of valproic acid-initiated homologous recombination.
Sha K; Winn LM
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):124-32. PubMed ID: 20437471
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of valproic acid on xenografted Kasumi-1 tumor growth in nude mouse and its mechanism].
Liu P; Tian X; Shi GR; Jiang FY; Liu BQ; Zhang ZH; Zhao L; Yan LN; Liang ZQ; Hao CL
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):458-62. PubMed ID: 22213865
[TBL] [Abstract][Full Text] [Related]
19. Effect of valproic acid on survival and neurologic outcomes in an asphyxial cardiac arrest model of rats.
Lee JH; Kim K; Jo YH; Lee SH; Kang C; Kim J; Park CJ; Kim MA; Lee MJ; Rhee JE
Resuscitation; 2013 Oct; 84(10):1443-9. PubMed ID: 23648213
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model.
Cetinkaya M; Cansev M; Cekmez F; Tayman C; Canpolat FE; Kafa IM; Yaylagul EO; Kramer BW; Sarici SU
PLoS One; 2015; 10(5):e0126028. PubMed ID: 25938838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
